Current advances in the non-chromatographic fractionation and characterization of PEGylated proteins

Journal of Chemical Technology and Biotechnology

Volumn 86, Issue 1, 2011, Pages 18-25

  Mayolo Deloisa, Karla ^a   González Valdez, José ^a   Guajardo Flores, Daniel ^a   Aguilar, Oscar ^a   Benavides, Jorge ^a   Rito Palomares, Marco ^a  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

Author keywords

Fractionation and analysis; Non chromatographic methods; PEGylated proteins; PEGylation

Indexed keywords

AQUEOUS TWO PHASE SYSTEM; BIOPHARMACEUTICAL INDUSTRY; CHROMATOGRAPHIC FRACTIONATION; CHROMATOGRAPHIC METHODS; CHROMATOGRAPHIC TECHNIQUES; ION EXCHANGE CHROMATOGRAPHY; PEGYLATED PROTEINS; PEGYLATION; PHYSICOCHEMICAL PROPERTY; PROTEIN CONJUGATES; THERAPEUTIC DRUGS;

CAPILLARY ELECTROPHORESIS; CHROMATOGRAPHIC ANALYSIS; ELECTROCHEMISTRY; FRACTIONATION; ION CHROMATOGRAPHY; ION EXCHANGE; PROTEINS; PURIFICATION; SIZE EXCLUSION CHROMATOGRAPHY; STEREOCHEMISTRY; ULTRAFILTRATION;

GEL PERMEATION CHROMATOGRAPHY;

ALPHA LACTALBUMIN; ALPHA2B INTERFERON; BOVINE SERUM ALBUMIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HORSERADISH PEROXIDASE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; INSULIN; LACCASE; LYSOZYME; MACROGOL; OVALBUMIN; PARATHYROID HORMONE; PROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN; RIBONUCLEASE A; STAPHYLOKINASE;

ANALYTIC METHOD; AQUEOUS TWO PHASE SYSTEM; CAPILLARY ELECTROPHORESIS; HUMAN; MEMBRANE SEPARATION TECHNIQUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN PURIFICATION; REVIEW; ULTRAFILTRATION;

EID: 78650052127     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.2498     Document Type: Review

References (47)

1. Veronese FM Pasut G, PEGylation, successful approach to drug delivery. Drug Discov Today 10: 1451-1458 (2005).
2. Bhadra D, Bhadra S, Jain P Jain NK, Pegnology: a review of PEG-ylated systems. Pharmazie 57: 5-29 (2002).
3. Scott MD Chen AM, Beyond the red cell: pegylation of other blood cells and tissues. Transfus Clin Biol 11: 40-46 (2004).
4. Harris JM Chess RB, Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2: 214-221 (2003).
5. Fee CJ Van Alstine JA, PEG-proteins: Reaction engineering and separation issues. Chem Eng Sci 61: 924-939 (2006).
6. Lee H Park TG, Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity. Pharm Res 19: 845-851 (2002).
7. Youn YS, Na DH, Yoo SD, Song S-C Lee KC, Chromatographic separation and mass spectrometric identification of positional isomers of polyethylene glycol-modified growth hormone-releasing factor (1-29). J Chromatogr A 1061: 45-49 (2004).
8. Pesek JJ, Matyska MT Krishnamoorthi V, Separation of polyethylene glycol-modified proteins by open tubular capillary electrochromatography. J Chromatogr A 1044: 317-322 (2004).
9. Snider J, Neville C, Yuan L-C Bullock J, Characterization of the heterogeneity of polyethylene glycol-modified superoxide dismutase by chromatographic and electrophoretic techniques. J Chromatogr A 599: 141-155 (1992).
10. Molek JR Zydney AL, Separation of PEGylated alpha-lactalbumin from unreacted precursors and byproducts using ultrafiltration. Biotechnol Prog 23: 1417-1424 (2007).
11. González-Valdez J, Cueto L, Benavides J Rito-Palomares M, Potential application of aqueous two-phase systems for the fractionation of RNase A and a-Lactalbumin from their PEGylated conjugates. J Chem Technol Biotechnol (In press).
12. Na DH Lee KC, Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 331: 322-328 (2004).
13. Na DH, Park EJ, Youn YS, Moon BW, Jo YW, Lee SH, et al, Sodium dodecyl sulfate-capillary gel electrophoresis of polyethylene glycolylated interferon alpha. Electrophoresis 25: 476-479 (2004).
14. Suo XY, Lu XL, Hu T, Ma GH Su ZG, A solid-phase adsorption method for PEGylation of human serum albumin and staphylokinase: preparation, purification and biochemical characterization. Biotechnol Lett 31: 1191-1196 (2009).
15. Zhai YQ, Zhao YJ, Lei JD, Su ZG Ma GH, Enhanced circulation half-life of site-specific PEGylated rhG-CSF: Optimization of PEG molecular weight. J Biotechnol 142: 259-266 (2009).
16. Edwards CK, Martin SW, Seely J, Kinstler O, Buckel S, Bendele AM, et al, Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. Adv Drug Deliv Rev 55: 1315-1336 (2003).
17. Molek J Zydney AL, Ultrafiltration characteristics of pegylated proteins. Biotechnol Bioeng 95: 474-482 (2006).
18. Latulippe DR, Molek JR Zydney AL, Importance of biopolymer molecular flexibility in ultrafiltration processes. Ind Eng Chem Res 48: 2395-2403 (2009).
19. Molek J, Ruanjaikaen K Zydney AL, Effect of electrostatic interactions on transmission of PEGylated proteins through charged ultrafiltration membranes. J Memb Sci 353: 60-69 (2010).
20. Benavides J Rito-Palomares M, Practical experiences from the development of aqueous two-phase processes for the recovery high value biological products. J Chem Technol Biotechnol 83: 133-142 (2008).
21. Park H-M, Lee S-W, Chang W-J Koo Y-M, Affinity separation by protein conjugated IgG in aqueous two-phase systems using horseradish peroxidase as a ligand carrier. J Chromatogr B 856: 108-112 (2007).
22. Picó G, Romanini D, Nerli B Farruggia B, Polyethyleneglycol molecular mass and polydispersivity effect on protein partitioning in aqueous two-phase systems. J Chromatogr B 830: 286-292 (2006).
23. Rosa PAJ, Azevedo AM Aires-Barros MR, Application of central composite design to the optimisation of aqueous two-phase extraction of human antibodies. J Chromatogr A 1141: 50-60 (2007).
24. Rito-Palomares M, Dale C Lyddiatt A, Generic application of an aqueous two-phase process for protein recovery from animal blood. Process Biochem 35: 665-673 (2000).
25. Delgado C, Malik F, Selisko B, Fisher D Francis GE, Quantitative-analysis of polyethylene-glycol (peg) in peg-modified proteins/cytokines by Aqueous 2-Phase Systems. J Biochem Biophys Methods 29: 237-250 (1994).
26. Delgado C, Malmsten M VanAlstine JM, Analytical partitioning of poly(ethylene glycol)-modified proteins. J Chromatogr B 692: 263-272 (1997).
27. Sookkumnerd T Hsu J, Purification of PEG-protein conjugates by countercurrent distribution in aqueous two-phase systems. J Liq Chromatogr Relat Technol 23: 497-503 (2000).
28. Johansson G, Andersson M Åkerlund H-E, Counter-current distribution of yeast enzymes with polymer-bound triazine dye affinity ligands. J Chromatogr A 298: 483-493 (1984).
29. Fee C, Protein conjugates purification and characterization, in PEGylated Protein Drugs: Basic Science and Clinical Applications, ed by Veronese F. Birkhäuser, Basel, Berlin, pp. 113-125 (2009).
30. Dou HZ, Zhang M, Zhang Y Yin CH, Synthesis and purification of mono-PEGylated insulin. Chem Biol Drug Des 69: 132-138 (2007).
31. Jeng FY Lin SC, Characterization and application of PEGylated horseradish peroxidase for the synthesis of poly(2-naphthol). Process Biochem 41: 1566-1573 (2006).
32. Hardy E, Ramon J, Saez V, Baez R, Tejeda Y Ruiz A, Detection of PEGylated proteins in polyacrylamide gels by reverse staining with zinc and imidazole salts. Electrophoresis 29: 2363-2371 (2008).
33. Park EJ Na DH, Microchip electrophoresis for monitoring covalent attachment of poly(ethylene glycol) to proteins. Anal Biochem 400: 304-306 (2010).
34. Yu T, Traina JA, Pungor Jr E McCaman M, Precise and comparative pegylation analysis by microfluidics and mass spectrometry. Anal Biochem 359: 54-62 (2006).
35. Patrick JS Lagu AL, Review applications of capillary electrophoresis to the analysis of biotechnology-derived therapeutic proteins. Electrophoresis 22: 4179-4196 (2001).
36. Hunt G Nashabeh W, Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: a biotechnology perspective. Anal Chem 71: 2390-2397 (1999).
37. Caliceti P Veronese FM, Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev 55: 1261-1277 (2003).
38. Na DH, Park EJ, Jo YW Lee KC, Capillary electrophoretic separation of high-molecular-weight poly(ethylene glycol)-modified proteins. Anal Biochem 373: 207-212 (2008).
39. Li WJ, Zhong Y, Lin BC Su ZG, Characterization of polyethylene glycol-modified proteins by semi-aqueous capillary electrophoresis. J Chromatogr A 905: 299-307 (2001).
40. Lee KS Na DH, Capillary electrophoretic separation of poly(ethylene glycol)-modified granulocyte-colony stimulating factor. Arch Pharm Res 33: 491-495 (2010).
41. Gaberc-Porekar V, Zore I, Podobnik B Menart V, Obstacles and pitfalls in the PEGylation of therapeutic proteins. Curr Opin Drug Discov Devel 11: 242-250 (2008).
42. Dalwadi G Sunderland B, Comparison and validation of drug loading parameters of PEGylated nanoparticles purified by a diafiltration centrifugal device and tangential flow filtration. Drug Dev Ind Pharm 34:(2008). DOI: 10.1080/03639040802098177. Latest info required.
43. Dalwadi G Sunderland VB, Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev Ind Pharm 33: 1030-1039 (2007).
44. Yun Q, Yang RE, Chen T, Bi JX, Ma GH Su ZG, Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography. J Biotechnol 118: 67-74 (2005).
45. Lopez-Cruz JI, Viniegra-Gonzalez G Hernandez-Arana A, Thermostability of native and pegylated Myceliophthora thermophila laccase in aqueous and mixed solvents. Bioconjug Chem 17: 1093-1098 (2006).
46. Papac DI Shahrokh Z, Mass spectrometry innovations in drug discovery and development. Pharm Res 18: 131-145 (2001).
47. Bobst CE, Abzalimov RR, Houde D, Kloczewiak M, Mhatre R, Berkowitz SA, et al, Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches. Anal Chem 80: 7473-7481 (2008).